摘要
目的通过观察血清可溶性CD105（sCD105）、高敏C反应蛋白（hs＋CRP）及心率震荡参数的变化，探讨阿托伐他汀强化治疗急性冠状动脉综合征（ACS）的效果及意义。方法将106例ACS患者按随机数字表法分为治疗1组（38例，常规治疗＋阿托伐他汀20mg）、治疗2组（38例，常规治疗＋阿托伐他汀40ms）和对照组（30例，仅给予常规治疗），测定三组治疗前及治疗4周后的心率震荡参数及sCD105、hs-CRP水平，并进行比较。结果治疗前三组震荡初始（T0）、震荡斜率（IS）、sCD105、hs-CRP比较差异无统计学意义（P〉0．05o治疗后三组TO、sCD105、hs．CRP均明显下降，偈明显升高（P〈0．05或〈0．01），而治疗2组改变最显著，治疗后治疗2组上述指标与治疗1组比较差异均有统计学意义[TO比较：（O．22±0．18）％比（0．66±0．23）％；TS比较：（6.22±0．83）ms／RR间期（RRI）比（3．90±0．73）ms／RRI；sCD105比较：（1．65±0．43）mg／L比（2．92±0．50）mg／L；hs．CRP比较：（1．68±0．55）m以比（2．08±0．61）mg／L]（P〈0．01）。相关分析表明，sCD105、hs-CRP水平与TO呈显著正相关（P〈0．01），而与偈呈显著负相关（P〈0．01）。结论ACS患者给予阿托伐他汀治疗，可稳定冠状动脉血管内皮及粥样斑块，改善自主神经功能，大剂量应用更能获益。
Objective To investigate the clinical effects and significance of different-dose atorvastatin on soluble CD105 （sCD105）,high sensitive-C reactive protein （hs-CRP） and the parameters of heart rate turbulence in patients with acute coronary syndrome （ACS）. Methods One hundred and six ACS patients were divided into three groups by random digits table： control group （30 patients, routine treatment）, treatment group I （38 patients, routine treatment ＋ atorvastatin 20 mg）, and treatment group Ⅱ （38 patients, routine treatment ＋ atorvastatin 40 rag）. All patients were treated for 4 Weeks. The levels of serum sCD105 ,hs-CRP,and the parameters of heart rate turbulence before and after treatment. Results Before treatment, the levels of turbulence onset （TO）, turbulence slope （TS）, sCD 105 and hs-CRP in three groups had no significant difference （P 〉 0.05 ）. After treatment, TO, sCD105 and hs-CRP decreased significantly, and TS increased significantly（P 〈 0.05 or 〈 0.01 ）. The change amphtude of treatment group Ⅱ was the most obvious, and the levels of above mentioned index showed significantly difference compared with that of treatment group I [TO： （0.22 ±0.18）% vs. （0.66±0.23）% ;TS： （6.22± 0.83） ms/RR interval （RRI） vs. （3.90 ±0.73） rns/RRI;sCD105：（1.65 ±0.43） mg/L vs.（2.92 ±0.50） mg/L;hs-CRP： （1.68 ±0.55） mg/L vs. （2.08 ± 0.61） mg/L] （P 〈0.01 ）. Correlation analysis showed the levels of sCD105 and hs-CRP had significantly positive correlation with TO （P 〈 0.01 ） and had negative correlation with TS （P 〈 0.01 ）. Conclusions The atorvastatin treatment in patients with ACS may stabilize eoronary vascular endothelial cells and atheroselerotie plaque, and improve autonomic nerve function. Larger doses of atorvastatin may get more benefit.
出处
《中国医师进修杂志》
2011年第7期14-17,共4页
Chinese Journal of Postgraduates of Medicine
